BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10346903)

  • 1. Separate oligosaccharide determinants mediate interactions of the low-molecular-weight salivary mucin with neutrophils and bacteria.
    Prakobphol A; Tangemann K; Rosen SD; Hoover CI; Leffler H; Fisher SJ
    Biochemistry; 1999 May; 38(21):6817-25. PubMed ID: 10346903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity.
    Prakobphol A; Thomsson KA; Hansson GC; Rosen SD; Singer MS; Phillips NJ; Medzihradszky KF; Burlingame AL; Leffler H; Fisher SJ
    Biochemistry; 1998 Apr; 37(14):4916-27. PubMed ID: 9538010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori.
    Prakobphol A; Borén T; Ma W; Zhixiang P; Fisher SJ
    Biochemistry; 2005 Feb; 44(6):2216-24. PubMed ID: 15697247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x.
    Karlsson NG; Thomsson KA
    Glycobiology; 2009 Mar; 19(3):288-300. PubMed ID: 19043084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria.
    Liu B; Rayment S; Oppenheim FG; Troxler RF
    Arch Biochem Biophys; 1999 Apr; 364(2):286-93. PubMed ID: 10190986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the ability of oral streptococci to interact with platelet glycoprotein Ibalpha and with the salivary low-molecular-weight mucin, MG2.
    Plummer C; Douglas CW
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):390-9. PubMed ID: 17069618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
    Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
    Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gel-forming mucin MUC5B--a nutrient for dental plaque bacteria.
    Wickström C; Svensäter G
    Oral Microbiol Immunol; 2008 Jun; 23(3):177-82. PubMed ID: 18402602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
    Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I
    Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Candida albicans adhesion to salivary mucin.
    Hoffman MP; Haidaris CG
    Infect Immun; 1993 May; 61(5):1940-9. PubMed ID: 8478083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1.
    Tu L; Murphy PG; Li X; Tedder TF
    J Immunol; 1999 Nov; 163(9):5070-8. PubMed ID: 10528213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of high-molecular-weight human salivary mucins.
    Offner GD; Troxler RF
    Adv Dent Res; 2000 Dec; 14():69-75. PubMed ID: 11842927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins.
    Hoskins LC; Agustines M; McKee WB; Boulding ET; Kriaris M; Niedermeyer G
    J Clin Invest; 1985 Mar; 75(3):944-53. PubMed ID: 3920248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin coatings suppress neutrophil adhesion to a polymeric model biomaterial.
    Sandberg T; Carlsson J; Ott MK
    Microsc Res Tech; 2007 Oct; 70(10):864-8. PubMed ID: 17576123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biosynthesis of human salivary mucins.
    Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
    Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal but not altered mucins activate neutrophils.
    Aknin ML; Berry M; Dick AD; Khan-Lim D
    Cell Tissue Res; 2004 Dec; 318(3):545-51. PubMed ID: 15490242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of type 1 fimbriae in the adhesion of Escherichia coli to salivary mucin and secretory immunoglobulin A.
    Moshier A; Reddy MS; Scannapieco FA
    Curr Microbiol; 1996 Sep; 33(3):200-8. PubMed ID: 8672098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolipids support E-selectin-specific strong cell tethering under flow.
    Burdick MM; Bochner BS; Collins BE; Schnaar RL; Konstantopoulos K
    Biochem Biophys Res Commun; 2001 Jun; 284(1):42-9. PubMed ID: 11374868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.